可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Araujo CC, Leon LL. Biological activities of curcuma longa L[J]. Mem Inst Oswaldo Cruz, 2001, 96(5):723-728.
[2] Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies[J]. Anticancer Res, 2003, 23(1A):363-398.
[3] Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin[J]. Cancer Lett, 2005, 223(2): 181-190.
[4] Quiles JL, Mesa MD, Ramirez-tortosa CL, et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits[J]. Arterioscler Thromb Vasc Biol, 2002, 22(7):1225-1231.
[5] Naito M, Wu X, Nomura H, et al. The protective efects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits[J]. J Atheroscler Thromb, 2002, 9(5):243-250.
[6] Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has atherosclerolemic efects in rabbits with experimental atherosclerosis[J]. Atherosclerosis, 1999, 147(2):371-378.
[7] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993, 362(6423):801-809.
[8] Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274(5293):1672-1677.
[9] Collins K, Jacks T, Pavletich NP. The cell cycle and cancer[J]. Proc Natl Acad Sci USA, 1997, 94(7):2776-2778.
[10]Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases[J]. Nature, 1993, 366(6456):701-704.
[11]Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21[J]. Cell, 1994, 78(1):67-74.
[12]Weiss RH, Joo A, Randour C. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation[J]. J Biol Chem, 2000, 275(14):10285-10290.